Missouri Judge Denies AG's Immediate Ban on 7-OH Kratom Sales, Signaling Ongoing Regulatory Scrutiny

Missouri Judge Denies AG's Immediate Ban on 7-OH Kratom Sales, Signaling Ongoing Regulatory Scrutiny

JEFFERSON CITY, MO – May 15, 2026 – A significant development in Missouri's ongoing debate surrounding kratom and its concentrated derivative, 7-hydroxymitragynine (7-OH), has emerged as a Jackson County judge denied Attorney General Catherine Hanaway's request for a temporary restraining order to immediately halt sales of these products by CBD American Shaman and its affiliates. This ruling, issued on May 8, 2026, marks a temporary reprieve for the targeted companies but underscores the intensifying regulatory and legal challenges facing the kratom industry in the state.

What Happened

Missouri Attorney General Catherine Hanaway initiated a lawsuit in March 2026 against CBD American Shaman, alleging that the company's sale of kratom and particularly its more potent 7-OH products constitutes "unlawful" and "deceptively marketed opioid-like drugs" under the Missouri Merchandising Practices Act. The lawsuit sought an immediate injunction to stop sales, citing public health concerns and the classification of 7-OH as a "hazardous opioid." However, the judge denied the motion for a temporary restraining order, stating there was insufficient evidence at this stage to conclude that the Attorney General would prevail in the broader lawsuit.

This legal action is part of a broader statewide investigation launched by Hanaway's office in November 2025, which has since expanded to include 22 entities across the kratom supply chain, from manufacturers to retailers. The investigation focuses on manufacturing, labeling, marketing, ingredients, testing, and alkaloid concentration, particularly concerning 7-OH products. Separately, the Missouri Department of Health and Senior Services has issued health advisories warning consumers about potential risks associated with 7-OH.

Why It Matters to Kratom Merchants and Consumers

This ruling provides a momentary pause for merchants selling 7-OH and kratom products in Missouri, preventing an immediate, statewide ban. However, it does not dismiss the underlying lawsuit or the Attorney General's ongoing investigations. The judicial denial of an immediate ban highlights the legal complexities and the differing scientific opinions surrounding 7-OH and kratom. The Attorney General's office presented arguments backed by law enforcement statements and FDA reports classifying 7-OH as a "potent opioid" and an "emerging public health threat," while American Shaman countered with expert testimonies asserting insufficient evidence of public health risk.

For consumers, the situation creates continued uncertainty regarding product availability and safety. The distinction between natural kratom and concentrated, chemically converted 7-OH remains a critical point of contention, with regulators increasingly targeting the latter due to concerns about its potency and potential for abuse.

Compliance Implications

Despite the recent judicial decision, the regulatory landscape in Missouri is clearly shifting towards stricter control over kratom and 7-OH. Legislative efforts are underway, with bills debated in the Missouri Senate that propose age restrictions (21+), bans on products mimicking candy, and a crucial limit of 2% on 7-OH content in kratom products. Local municipalities, such as Kirksville, have already enacted ordinances imposing age limits and strict labeling requirements. The ongoing investigations, coupled with potential legislative changes, indicate a high-risk environment for businesses in this sector.

What High-Risk Merchants Need to Know

For high-risk kratom merchants, proactive and rigorous compliance is no longer optional but essential for survival.

1. Comprehensive COAs and Lab Testing: Merchants must prioritize robust, third-party lab testing for all products. This includes detailed Certificates of Analysis (COAs) that clearly quantify alkaloid profiles, especially mitragynine and 7-OH levels. Given the proposed 2% 7-OH limit, precise measurement of this compound is paramount.
2. Ingredient Transparency: Full disclosure of all ingredients, including any synthetic or concentrated derivatives, is crucial for consumer safety and regulatory compliance.
3. Accurate Labeling and Marketing: All product labeling and marketing materials must be truthful, non-misleading, and avoid any unsubstantiated health claims. Merchants should avoid marketing products in ways that appeal to children, such as candy-like forms.
4. Age Verification: Implement strict age verification protocols to ensure sales are only made to individuals 21 years or older, aligning with proposed state legislation and existing local ordinances.
5. Stay Informed: Continuously monitor state and local legislative developments, as well as actions by the Attorney General's office and the FDA. Ignorance of evolving regulations will not be a defense.
6. Supply Chain Diligence: Understand your entire supply chain. The Attorney General's expanded investigation targets manufacturers, distributors, and retailers, emphasizing the need for due diligence at every level.

The denial of the immediate sales halt offers a temporary reprieve, but the spotlight on 7-OH and kratom in Missouri is brighter than ever. Merchants must adapt to this heightened scrutiny by embracing transparency, rigorous testing, and strict adherence to current and anticipated regulations to safeguard their businesses and consumers.